Src-Mediated Cross-Talk between Farnesoid X and Epidermal Growth Factor Receptors Inhibits Human Intestinal Cell Proliferation and Tumorigenesis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Src-Mediated Cross-Talk between Farnesoid X and Epidermal Growth Factor Receptors Inhibits Human Intestinal Cell Proliferation and Tumorigenesis
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 10, Pages e48461
Publisher
Public Library of Science (PLoS)
Online
2012-11-01
DOI
10.1371/journal.pone.0048461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion
- (2011) Angelica Belo et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells
- (2011) Jean-Pierre Raufman et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression
- (2011) C Giordano et al. ONCOGENE
- Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease
- (2010) Raffaella M. Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor
- (2010) D. L. H. Smith et al. CARCINOGENESIS
- Convergence between Wnt-β-catenin and EGFR signaling in cancer
- (2010) Tianhui Hu et al. Molecular Cancer
- Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells
- (2009) Guofeng Xie et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Guggulsterone induces apoptosis in colon cancer cells and inhibits tumor growth in murine colorectal cancer xenografts
- (2009) Min Ji An et al. CANCER LETTERS
- Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
- (2009) J. Veeken et al. CURRENT CANCER DRUG TARGETS
- Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways
- (2008) Thomas Haarmann-Stemmann et al. BIOCHEMICAL PHARMACOLOGY
- Genetic Ablation of M3 Muscarinic Receptors Attenuates Murine Colon Epithelial Cell Proliferation and Neoplasia
- (2008) J.-P. Raufman et al. CANCER RESEARCH
- Guggulsterone, a Farnesoid X Receptor Antagonist, Inhibits Constitutive and Inducible STAT3 Activation through Induction of a Protein Tyrosine Phosphatase SHP-1
- (2008) K. S. Ahn et al. CANCER RESEARCH
- Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis
- (2008) S. Modica et al. CANCER RESEARCH
- Guggulsterone modulates MAPK and NF- B pathways and inhibits skin tumorigenesis in SENCAR mice
- (2008) S. Sarfaraz et al. CARCINOGENESIS
- FXR: a metabolic regulator and cell protector
- (2008) Yan-Dong Wang et al. CELL RESEARCH
- Guggulsterone: A potent farnesoid X receptor antagonist and its rapidly evolving role as a systemic anticarcinogenic agent
- (2008) Shailendra Kapoor HEPATOLOGY
- Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development
- (2008) R. R.M. Maran et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Crosstalk between G-protein-coupled receptors and Epidermal growth factor receptor in cancer
- (2007) Neil et al. Frontiers in Bioscience-Landmark
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now